Rossi R L, Jenkins R L, Nielsen-Whitcomb F F
Surg Clin North Am. 1985 Apr;65(2):231-62. doi: 10.1016/s0039-6109(16)43580-2.
The management of portal hypertension focuses on control of its complications, the most important of which is bleeding esophageal varices. Other complications, such as ascites, bleeding intestinal stomas, and hypersplenism, rarely require surgical intervention. Other than medical management, the three basic procedures now available for the treatment of bleeding esophageal varices include decompression of varices with a portosystemic shunt, nonshunting operations that attack directly the esophageal variceal-bearing area, and liver transplantation as the procedure of choice in selected patients. Patients who present with episodes of acute bleeding are usually treated initially with medical therapy including acute sclerotherapy or balloon tamponade techniques when necessary. If the patient fails to respond or if episodes of bleeding recur, further therapy is required. Although selection of therapy remains controversial, it is based on multiple factors. These include the basic pathogenic mechanism of portal hypertension in the individual patient, status of the patient as defined by Child's classification, elective or urgent nature of the operation, hemodynamic stability of the patient at the time of the procedure, site of the block in the portal system, and caliber and anatomic relationship of the vessels available for anastomosis in the portal system. Additional factors include the presence and severity of ascites or encephalopathy, age of the patient, site of bleeding (esophageal or gastric), severity of associated hypersplenism, and techniques and expertise available at a given institution. Shunting procedures achieve the best long-term control of bleeding, but they can precipitate the development of encephalopathy. Nonshunting procedures do not induce encephalopathy, but they are usually associated with a high rate of rebleeding. Also, with the possible exception of sclerotherapy, they are still associated with a high operative mortality rate in alcoholic patients classified as Child's C. Although sclerotherapy controls acute variceal bleeding more successfully than conventional methods, it is not readily applicable in patients with bleeding gastric varices. Also, it has not yet clearly been proved to be an effective method of permanent control of gastroesophageal bleeding and has not been demonstrated to increase survival. The new methods of extensive esophagogastric devascularization (for example, porta-azygos disconnection using the Sugiura procedure) are attractive because of the low late recurrence rate for bleeding without the induction of encephalopathy.(ABSTRACT TRUNCATED AT 400 WORDS)
门静脉高压的治疗重点在于控制其并发症,其中最重要的是食管静脉曲张出血。其他并发症,如腹水、肠造口出血和脾功能亢进,很少需要手术干预。除了药物治疗外,目前用于治疗食管静脉曲张出血的三种基本方法包括:通过门体分流术使曲张静脉减压、直接针对食管曲张静脉所在区域的非分流手术,以及在特定患者中作为首选手术的肝移植。出现急性出血发作的患者通常首先接受药物治疗,必要时包括急性硬化疗法或气囊压迫技术。如果患者无反应或出血复发,则需要进一步治疗。尽管治疗方法的选择仍存在争议,但它基于多种因素。这些因素包括个体患者门静脉高压的基本发病机制、根据Child分级确定的患者状况、手术的择期或紧急性质、手术时患者的血流动力学稳定性、门静脉系统阻塞部位、门静脉系统中可用于吻合的血管口径和解剖关系。其他因素包括腹水或肝性脑病的存在和严重程度、患者年龄、出血部位(食管或胃)、相关脾功能亢进的严重程度,以及特定机构可用的技术和专业知识。分流手术能实现对出血的最佳长期控制,但可能会促使肝性脑病的发生。非分流手术不会诱发肝性脑病,但通常再出血率较高。此外,除了硬化疗法可能例外,对于Child C级的酒精性患者,它们的手术死亡率仍然很高。尽管硬化疗法比传统方法更成功地控制急性曲张静脉出血,但它不适用于胃静脉曲张出血的患者。而且,尚未明确证明它是永久控制胃食管出血的有效方法,也未证明能提高生存率。广泛的食管胃去血管化新方法(例如,使用Sugiura手术进行门奇静脉断流)很有吸引力,因为出血的晚期复发率低且不会诱发肝性脑病。(摘要截选至400字)